We only have this paper's title and publication details.
Read it at the sourceAssesses safety and efficacy of riliprubart in CIDP, suggesting promising outcomes.
To report efficacy and safety of riliprubart at Week-76.
No takes yet. Share an insight, caveat, or question.
Querol et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: